Do high proinsulin and C-peptide levels play a role in autonomic nervous dysfunction?: Power spectral analysis in patients with non-insulin-dependent diabetes and nondiabetic subjects

Circulation

Volumn 96, Issue 4, 1997, Pages 1185-1191

  Töyry, Jari P ^a   Niskanen, Leo K ^a   Mäntysaari, Matti J ^a,c   Länsimies, Esko A ^a   Haffner, Steven M ^b   Miettinen, Heikki J J ^b   Uusitupa, Matti I J ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c CENTRAL MILITARY HOSPITAL   (Finland)

Author keywords

Autonomic; Diabetes mellitus; Insulin; Nervous system

Indexed keywords

C PEPTIDE; PROINSULIN;

ADULT; AGED; ARTICLE; AUTONOMIC NEUROPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPECTROSCOPY; SYMPATHETIC TONE;

EID: 0342601937     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.4.1185     Document Type: Article

References (45)

1. Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med. 1980;49:95-108.
2. Sampson MJ, Wilson S, Karagiannis P, Edmonds M, Watkins PJ. Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics. Q J Med. 1990;278:635-646.
3. Töyry JP, Niskanen LK, Mäntysaari MJ, Länsimies EA, Uusitupa MIJ. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM: ten-year follow-up from the diagnosis. Diabetes. 1996;45:308-315.
4. Tack CJJ, Smits P, Willemsen JJ, Lenders JWM, Thien T, Lutterman JA. Effects of insulin on vascular tone and sympathetic nervous system in NIDDM. Diabetes. 1996;45:15-22.
5. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care. 1979;2:131-141.
6. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979;2:154-160.
7. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia. 1980;19:205-210.
8. Despres J-P, Lamarche B, Mauriege P, Cantin P, Dagenais GR, Moorjani S, Lupien P-J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952-957.
9. Temple RC, Clark P, Schneider A, Naki DK, Yudkin JS, Hales CN. Insulin deficiency in non-insulin dependent diabetes. Lancet. 1989; 1:293-295.
10. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte U. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia. 1987;30:698-702.
11. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamato Y. Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1988;31:355-360.
12. Temple RC, Clark P, Schneider A, Nagi DK, Yudkin JS, Hales CN. Radioimmunoassay may overestimate insulin in non-insulin dependent diabetics. Clin Endocrinol. 1990;32:689-693.
13. Saad MF, Kahn SE, Nelson RG, Pettitt DJ, Knowler WC, Schwartz MW, Kowalyk S, Bennett PM, Porte D. Disproportionately elevated proinsulin in Pima Indians with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab. 1990;70:1247-1253.
14. Porte D. Banting Lecture 1990: β cells in type II diabetes mellitus. Diabetes. 1991;40:166-180.
15. Davies MJ, Metcalfe J, Gray IP, Day JL, Hales CN. Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type II diabetes mellitus. Diabet Med. 1993;10:305-312.
16. Reaven GM, Chen YDI, Hollenbeck CB, Hseuh WH, Ostrega D, Polonsky KS. Plasma insulin, C-peptide, and proinsulin concentrations in obese and non-obese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab. 1993;76:44-48.
17. Davies M, Rayman G, Gray IP, Day JL, Hales CN. Insulin deficiency and increased plasma concentrations of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabet Med. 1993;10:313-320.
18. Hales CN. The pathogenesis of NIDDM. Diabetologia. 1994; 37(suppl 2):S162-S168.
19. Wahren J, Johansson B-L, Wallberg-Henriksson H. Does C-peptide have a physiological role? Diabetologia. 1994;34(suppl 2):S99-S107.
20. Ewing JE, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985;5:491-498.
21. Akselrod S, Gordon D, Ubel FA, Schannon DC, Barger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science. 1981; 213:220-223.
22. Akselrod S, Gordon D, Madwed JB, Snidman NC, Shannon DC, Cohen RJ. Hemodynamic regulation: investigation by spectral analysis. Am J Physiol. 1985;249:H867-H875.
23. Parati G, Saul JP, Di Rienzo M, Mancia G. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation: a critical appraisal. Hypertension. 1995;25:1276-1286.
24. Fei L. Effects of pharmacological interventions on heart rate variability: animal experiments and clinical observations. In: Malik M, Camm AJ, eds. Heart Rate Variability. New York, NY: Futura Publishing Co, Inc; 1995:275-291.
25. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia. 1993; 36:1175-1184.
26. Uusitupa M, Siitonen O, Pyörälä K, Aro A, Hersio K, Penttilä I, Voutilainen E. The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed type 2 (non-insulin-dependent) diabetes. Diabetologia. 1985;28:653-659.
27. WHO Expert Committee on Diabetes Mellitus. Second Report. Technical Report Series, No. 646. Geneva, Switzerland: World Health Organization; 1980.
28. Niskanen L, Karjalainen J, Siitonen O, Uusitupa M. Metabolic evolution of type 2 diabetes: a 10-year follow-up from the time of diagnosis. J Int Med. 1994;236:263-270.
29. Rose GA, Blackburn H. Cardiovascular survey methods. WHO Monograph Series, No. 56. Geneva, Switzerland: World Health Organization; 1968.
30. Bowsher RR, Wolny JD, Frank BH. A rapid and sensitive immunoassay for the measurement of proinsulin in human serum. Diabetes. 1992;41:1084-1090.
31. Haffner SM, Stern MP, Miettinen H, Gingerich R, Bowsher RR. Higher proinsulin and specific insulin are both associated with a parental history of diabetes in non-diabetic Mexican American subjects. Diabetes. 1995;44:1156-1160.
32. Penttilä IM, Voutilainen E, Laitinen O, Juutilainen P. Comparison of different analytical and precipitation methods for the direct estimation of serum high-density lipoprotein cholesterol. Scand J Clin Lab Invest. 1981;41:353-360.
33. Tahvanainen K, Länsimies E, Tikkanen P, Hartikainen J, Kärki T, Lyyra T, Mäntysaari M. Microcomputer-based monitoring of cardiovascular functions in simulated microgravity. Adv Space Res. 1992;12:1227-1236.
34. Engelese WAH, Zeelenberg C. A single scan algorithm for QRS-detection and feature extraction. In: Ripley KL, Ostrow HG, eds. IEEE Computers in Cardiology. Long Beach, Calif: IEEE Computer Society; 1979:37-42.
35. Von Neumann J, Kent RH, Bellinson HR, Hart BI. The mean square successive difference. Ann Math Stat. 1941;12:153-162.
36. Fouad FM, Tarazi RC, Ferrario CM, Fighaly S, Alicandri C. Assessment of parasympathetic control of heart rate by a noninvasive method. Am J Physiol. 1984;246:H838-H842.
37. Billman GE, Dujardin JP. Dynamic changes in cardiac vagal tone as measured by time series analysis. Am J Physiol. 1990;258: H896-H902.
38. Hayano J, Sakakibara Y, Yamada A, Yamada M, Mukai S, Fujinami T, Yokoyama K, Watanabe Y, Takata K. Accuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects. Am J Cardiol. 1991;67:199-204.
39. Akselrod S. Components of heart rate variability: basic studies. In: Malik M, Camm AJ, eds. Heart Rate Variability. New York, NY: Futura Publishing Co, Inc; 1995:147-163.
40. Hedman A. Short-term Oscillations in Cardiovascular Control System. Kuopio, Finland: University of Kuopio; 1995. Thesis.
41. Kautzner J, Hnatkova K. Correspondence of different methods for heart rate variability measurement. In: Malik M, Camm AJ, eds. Heart Rate Variability. New York, NY: Futura Publishing Co, Inc; 1995:119-126.
42. Kamath MV, Fallen EL. Correction of the heart rate variability signal for ectopic and missing beats. In: Malik M, Camm AJ, eds. Heart Rate Variability. New York, NY: Futura Publishing Co, Inc; 1995:75-85.
43. Nagi DK, Hendra TJ, Ryle AJ, Cooper TM, Temple RC, Clark PM, Schneider AE, Hales CN, Yudkin JS. The relationship of concentrations of insulin, intact proinsulin, and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects. Diabetologia. 1990;33:532-537.
44. Haffner SM, Mykkänen L, Stern MP, Valdez RA, Heisserman JA, Bowsher RR. Relationship of proinsulin and insulin to cardiovascular risk factors in non-diabetic subjects. Diabetes. 1993;42: 1297-1302.
45. Macdonald IA. The sympathetic nervous system and its influence on metabolic function. In: Bannister R, Mathias CJ, eds. Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System. Oxford, UK: Oxford University Press; 1992:197-211.